Approvals accorded under Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country
The Indian pharmaceutical industry is the 3rd largest in the world by volume. It has high market presence in several advanced economies such as the US and EU. The industry is well known for its production of affordable medicines, particularly in the generics space. However, the country is significantly dependent on the import of basic […]
Quality Medicines
As per information provided by the Central Drugs Standard Control Organization (CDSCO) under the Ministry of Health & Family Welfare, the Organization regulates safety, efficacy and quality of the drugs, medical devices and Cosmetics as per the provisions of Drugs and Cosmetics Act 1940 & Rules made thereunder. CDSCO and Ministry of Health & Family […]
Treatment of Rare Diseases
The Department of Health and Family Welfare has launcheda Digital Portal for Crowd funding and Voluntary donations for Patients of Rare Diseases in accordance with the mandate of the National Policy for Rare Diseases, 2021. The Digital Portal may be accessed through https://rarediseases.nhp.gov.in/ (c): ICMR has initiated a National Registry wherein epidemiological data is being […]
Dr Bharati Pravin Pawar addresses International Symposium on Health Technology Assessment
Union Minister of State for Health and Family Welfare, Dr Bharati Pravin Pawar addressed International Symposium on Health Technology Assessment, was organised by the Department of Health Research, Ministry of Health and Family Welfare in collaboration with International Decision Support Initiative (iDSI). The theme of the event was “Translating Knowledge and Best Practices into Policy […]
Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19
EMA’s CHMP recommended the approval yesterday Approval based on results from four phase III studies in over 5,500 patients. Actemra/RoActemra has also been provisionally approved in Australia for the treatment of COVID-19. Basel, 07 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has extended the marketing authorisation for […]
Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in countries accepting the CE Mark to enable rapid differentiation of viral respiratory infections
The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with results ready in less than 30 minutes, allowing informed decisions on patient and pandemic management decisions. Affordable and small, instrument-free testing kit enables convenient use for healthcare professionals at different point of care locations and in resource-limited settings. […]
CHMP recommends EU approval of Actemra/RoActemra to treat patients with severe COVID-19
Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase III studies The European Commission is expected to make a final decision regarding approval in the near future Basel, 06 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency’s […]
WHO advises against use of convalescent plasma for covid-19
Current evidence shows no improvement in survival and other important measures Convalescent plasma (a transfusion of blood plasma from someone who has recovered from covid-19) is not recommended for patients with covid-19, says a WHO Guideline Development Group of international experts in The BMJ today. Despite its initial promise, current evidence shows that it does […]
Steps Taken by Government against Excess Charges Being Levied by Private Hospitals
Health being a State subject, it is the responsibility of the respective State/Union Territory (UT) Government to take cognizance of complaints against private hospitals including for charging excess fees for the same procedures from the patients paying in cash as compared to those who pay through cashless health insurance schemes and to take suitable action […]
Hon’ble PM Shri Narendra Modi inaugrates ICMR-RMRCGKP Gorakhpur's new centre of medical research excellence
The inaugration was also attended by the Chief Minister, Shri Yogi Adityanath ; UP Governor, Smt. Anandiben Patel and Secretary, Department of Health Research & DG-ICMR, Prof (Dr.) Balram Bhargava. Gorakhpur, 7 December 2021: Hon’ble Prime Minister Shri Narendra Modi inaugurated the new centre of medical research excellence at Indian Council of Medical Research’s Regional […]
